BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
2601
DELISTED
Exact Sciences
EXAS
| $10.7K | ﹤0.01% |
913
-17,905
| -95% | -$205K |
|
|
NTK
2602
DELISTED
NORTEK INC COM NEW (DE)
NTK
| $10.7K | ﹤0.01% |
+143
| New | +$10.2K |
|
2603
ICU Medical
ICUI
$4.58B
| $10.6K | ﹤0.01% |
167
-3,340
| -95% | -$215K |
|
|
IPCC
2604
DELISTED
Infinity Property & Casualty C
IPCC
| $10.6K | ﹤0.01% |
148
-2,981
| -95% | -$204K |
|
2605
VirnetX Holding Corp
VHC
$65.3M
| $10.6K | ﹤0.01% |
+27
| New | +$10.8K |
|
2606
Tompkins Financial
TMP
$1.46B
| $10.6K | ﹤0.01% |
+206
| New | +$10K |
|
2607
LivePerson
LPSN
$36.3M
| $10.6K | ﹤0.01% |
48
-953
| -95% | -$158K |
|
|
LOGM
2608
DELISTED
LogMein, Inc.
LOGM
| $10.6K | ﹤0.01% |
315
-6,379
| -95% | -$204K |
|
2609
Zurn Elkay Water Solutions
ZWS
$8.4B
| $10.6K | ﹤0.01% |
+812
| New | +$9.17K |
|
|
BERY
2610
DELISTED
Berry Global Group, Inc.
BERY
| $10.6K | ﹤0.01% |
782
-15,830
| -95% | -$301K |
|
|
AXON
2611
Axon Enterprise
AXON
$49.6B
| $10.5K | ﹤0.01% |
664
-13,173
| -95% | -$214K |
|
2612
Insperity
NSP
$1.99B
| $10.5K | ﹤0.01% |
582
-11,524
| -95% | -$207K |
|
2613
World Acceptance Corp
WRLD
$899M
| $10.5K | ﹤0.01% |
120
-2,466
| -95% | -$230K |
|
|
ECOL
2614
DELISTED
US Ecology, Inc.
ECOL
| $10.5K | ﹤0.01% |
+282
| New | +$9.75K |
|
|
UTEK
2615
DELISTED
Ultratech Inc.
UTEK
| $10.4K | ﹤0.01% |
360
-7,221
| -95% | -$192K |
|
|
ZINC
2616
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $10.4K | ﹤0.01% |
643
-11,535
| -95% | -$160K |
|
2617
PUT
Union Pacific
UNP
$178B
| $10.4K | ﹤0.01% |
3,610
-618
| -15% | -$48.9K |
|
2618
The Greenbrier Companies
GBX
$1.42B
| $10.4K | ﹤0.01% |
+316
| New | +$9.29K |
|
2619
Chefs' Warehouse
CHEF
$4.6B
| $10.3K | ﹤0.01% |
+354
| New | +$8.83K |
|
2620
Standex International
SXI
$3.98B
| $10.3K | ﹤0.01% |
164
-3,333
| -95% | -$202K |
|
2621
OFG Bancorp
OFG
$2.26B
| $10.3K | ﹤0.01% |
592
-11,978
| -95% | -$194K |
|
|
CMA
2622
CALL
DELISTED
Comerica
CMA
| $10.2K | ﹤0.01% |
+38
| New | +$1.67K |
|
|
CNSL
2623
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $10.2K | ﹤0.01% |
520
-10,531
| -95% | -$197K |
|
2624
Piper Sandler
PIPR
$5.5B
| $10.2K | ﹤0.01% |
+1,032
| New | +$9.41K |
|
|
CEC
2625
DELISTED
CEC ENTERTAINMENT INC
CEC
| $10.2K | ﹤0.01% |
230
-4,541
| -95% | -$206K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.